Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1449
Publisher
MDPI AG
Online
2019-09-27
DOI
10.3390/cancers11101449
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Pilot Clinical Study on the Prognostic Relevance of Plasmatic Exosomes Levels in Oral Squamous Cell Carcinoma Patients
- (2019) Samuel Rodríguez Zorrilla et al. Cancers
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis
- (2018) Alessandro Sciarra et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Circulating Extracellular Vesicles in Human Disease
- (2018) Ravi Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microenvironmental pH and Exosome Levels Interplay in Human Cancer Cell Lines of Different Histotypes
- (2018) Mariantonia Logozzi et al. Cancers
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
- (2016) Stefano Fais et al. ACS Nano
- Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study
- (2015) Valeria Panebianco et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods
- (2015) Tamás Baranyai et al. PLoS One
- Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
- (2014) Andrew J Vickers et al. BMC Medicine
- Prostate Cancer Biomarker Profiles in Urinary Sediments and Exosomes
- (2013) Siebren Dijkstra et al. JOURNAL OF UROLOGY
- Screening for Prostate Cancer
- (2011) Richard M. Hoffman NEW ENGLAND JOURNAL OF MEDICINE
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- Can urinary exosomes act as treatment response markers in prostate cancer?
- (2009) Paul J Mitchell et al. Journal of Translational Medicine
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study
- (2009) Katja Fall et al. PLOS MEDICINE
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Serum Markers for Prostate Cancer: A Rational Approach to the Literature
- (2008) Thomas Steuber et al. EUROPEAN UROLOGY
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
- (2008) Khalid Al-Nedawi et al. NATURE CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started